VRNA logo

Verona Pharma (VRNA) Revenue

Annual Revenue

N/A

31 December 2023

VRNA Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Revenue

$5.62 M
0.00%

30 September 2024

VRNA Quarterly Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Revenue

$5.62 M
0.00%

30 September 2024

VRNA TTM Revenue Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VRNA Revenue Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years--85.9%-85.9%
5 y5 years---

VRNA Revenue High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-85.9%+1128.0%-85.9%+1128.0%
5 y5 years-85.9%+1128.0%-85.9%+1128.0%
alltimeall time-85.9%+1128.0%-85.9%+1128.0%

Verona Pharma Revenue History

DateAnnualQuarterlyTTM
Sept 2024
-
$5.62 M(+1127.9%)
$5.62 M(+1127.9%)
Dec 2022
$458.00 K(-98.9%)
$458.00 K
$458.00 K
DateAnnualQuarterlyTTM
Dec 2021
$40.00 M
-
-
Sept 2021
-
$40.00 M
$40.00 M

FAQ

  • What is the all time high annual revenue for Verona Pharma?
  • What is Verona Pharma quarterly revenue?
  • What is the all time high quarterly revenue for Verona Pharma?
  • What is Verona Pharma TTM revenue?
  • What is the all time high TTM revenue for Verona Pharma?

What is the all time high annual revenue for Verona Pharma?

Verona Pharma all-time high annual revenue is $40.00 M

What is Verona Pharma quarterly revenue?

The current quarterly revenue of VRNA is $5.62 M

What is the all time high quarterly revenue for Verona Pharma?

Verona Pharma all-time high quarterly revenue is $40.00 M

What is Verona Pharma TTM revenue?

The current TTM revenue of VRNA is $5.62 M

What is the all time high TTM revenue for Verona Pharma?

Verona Pharma all-time high TTM revenue is $40.00 M